These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19523328)

  • 41. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.
    Giordano A; Galderisi U; Marino IR
    J Cell Physiol; 2007 Apr; 211(1):27-35. PubMed ID: 17226788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
    Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
    Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenchymal stem cell therapy for cardiac repair.
    Boyle AJ; McNiece IK; Hare JM
    Methods Mol Biol; 2010; 660():65-84. PubMed ID: 20680813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mesenchymal stem cells and potential applications in treating ocular disease.
    Joe AW; Gregory-Evans K
    Curr Eye Res; 2010 Nov; 35(11):941-52. PubMed ID: 20958182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological considerations of mesenchymal stem cells and endothelial progenitor cells.
    Papathanasopoulos A; Giannoudis PV
    Injury; 2008 Sep; 39 Suppl 2():S21-32. PubMed ID: 18804570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current status of stem cell therapy for liver diseases.
    Souza BS; Nogueira RC; de Oliveira SA; de Freitas LA; Lyra LG; Ribeiro dos Santos R; Lyra AC; Soares MB
    Cell Transplant; 2009; 18(12):1261-79. PubMed ID: 19660179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of mesenchymal stromal cells for myocardial infarction. Transitioning from bench to bedside.
    Psaltis PJ; Spoon DB; Wong DT
    Minerva Cardioangiol; 2013 Dec; 61(6):639-63. PubMed ID: 24253457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular therapy in 2010: focus on autoimmune and cardiac diseases.
    Perl L; Weissler A; Mekori YA; Mor A
    Isr Med Assoc J; 2010 Feb; 12(2):110-5. PubMed ID: 20550037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mesenchymal stem cells: A therapeutic update].
    Jorgensen C; Deschaseaux F; Planat-Benard V; Gabison E
    Med Sci (Paris); 2011 Mar; 27(3):275-84. PubMed ID: 21447297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential therapeutic application of mesenchymal stem cells in ophthalmology.
    Zakirova EY; Valeeva AN; Aimaletdinov AM; Nefedovskaya LV; Akhmetshin RF; Rutland CS; Rizvanov AA
    Exp Eye Res; 2019 Dec; 189():107863. PubMed ID: 31669045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integration of mesenchymal stem cells with nanobiomaterials for the repair of myocardial infarction.
    Han J; Park J; Kim BS
    Adv Drug Deliv Rev; 2015 Dec; 95():15-28. PubMed ID: 26390936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Boosting acute myocardial infarction treatment with stem cells.
    Taylor J
    Eur Heart J; 2014 Apr; 35(16):1015-6. PubMed ID: 24877217
    [No Abstract]   [Full Text] [Related]  

  • 54. Stem cell therapies for treatment of cartilage and bone disorders: osteoarthritis, avascular necrosis, and non-union fractures.
    Sampson S; Botto-van Bemden A; Aufiero D
    PM R; 2015 Apr; 7(4 Suppl):S26-S32. PubMed ID: 25864657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mesenchymal stem cell therapy, a new hope for eye disease].
    Roubeix C; Denoyer A; Brignole-Baudouin F; Baudouin C
    J Fr Ophtalmol; 2015 Oct; 38(8):764-75. PubMed ID: 26215486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell-based therapies for ocular inflammation.
    Forrester JV; Steptoe RJ; Klaska IP; Martin-Granados C; Dua HS; Degli-Esposti MA; Wikstrom ME
    Prog Retin Eye Res; 2013 Jul; 35():82-101. PubMed ID: 23542232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stem cell therapy for ocular disorders.
    Levin LA; Ritch R; Richards JE; Borrás T
    Arch Ophthalmol; 2004 Apr; 122(4):621-7. PubMed ID: 15078681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stem cells and myocardial regeneration: cooperation wins over competition.
    Leri A; Anversa P
    Circulation; 2013 Jan; 127(2):165-8. PubMed ID: 23224060
    [No Abstract]   [Full Text] [Related]  

  • 59. Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?
    Low PA; Gilman S
    Ann Neurol; 2012 Jul; 72(1):4-5. PubMed ID: 22829263
    [No Abstract]   [Full Text] [Related]  

  • 60. [Potential applications of mesenchymal stem cells in ocular diseases].
    Zhang XM; Li XR
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):956-60. PubMed ID: 23342388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.